United Kingdom
UK / English
Choose your region
Choose your language
Register
Mast_Group.svg
ProductsMarketsAboutResourcesNews & Events
Contact us
ProductsMarketsAboutResourcesNews & Events
logo-mast.svg
+44 (0) 151 933 7277
Email us
Sign up to Newsletter
Products
  • Gastrointestinal Diseases
  • Immunology
  • Microbiology
  • Molecular
  • Pharmaceutical Services
  • Urinalysis
Markets
  • Clinical Diagnostics
  • FIT testing
  • Infectious Disease
  • Pharmaceutical & Industrial
  • Point of Care
  • Veterinary
About
  • Careers
  • Our Culture
  • Our Governance
  • Our History
  • Our Locations
  • Our Partners
  • Our Quality
Resources
  • Faqs
  • Certificates of Analysis
  • Quality Certification
News & Events
  • News
  • Events
  • Blog
United Kingdom
UK / English
Manage Cookies|
Terms & conditions|
Privacy and Data Protection|
Policy Ordering Information|
Terms and Conditions For Supply of Goods and/or Services|
Standard Conditions of Purchase
|© Mast Group Ltd. 2026
Follow Us
LinkedIn.svgUK
© Mast Group Ltd. 2026
Syndromic PCR AssaysSyndromic PCR Assays
Home
MolecularSyndromic PCR Assays

Syndromic PCR Assays

We offer solutions that can be adapted to suit your laboratories clinical pathway, throughput and workflow needs. Flexibility can be achieved through a range of assays and automation in addition to maintenance and service offerings.

MAST ISOPLEXSyndromic PCR AssaysSyndromic PCR Instruments & LabwareAccessories & Consumables
  • Molecular_Pipetting_PinkMolecular_Pipetting_Pink
Syndromic PCR Assays
Human Papilloma Virus (HPV)
HPV molecular assays detect high-risk Human Papillomavirus (hrHPV) DNA or mRNA, serving as the primary screening tool for cervical cancer by identifying infection before cell abnormalities appear
Human Papilloma Virus (HPV)
  • Mast.jpgMast.jpg
    Syndromic PCR Assays
    Extraction
    Flexible & Automated Extraction Methods
    Extraction
  • Mast.jpgMast.jpg
    Syndromic PCR Assays
    Healthcare Acquired Infection (HAI)
    Molecular assays for healthcare acquired infections (HAIs) providing rapid, highly sensitive detection of pathogens and resistance genes
    Healthcare Acquired Infection
  • Mast.jpgMast.jpg
    Syndromic PCR Assays
    Gastrointestinal
    Gastrointestinal (GI) molecular assays for rapid, highly sensitive diagnostic tools that simultaneously detect bacterial, viral, and parasitic pathogens from stool samples
    Gastrointestinal
  • Mast.jpgMast.jpg
    Syndromic PCR Assays
    Meningitis
    Molecular assays for meningitis to provide rapid, sensitive identification of bacteria, viruses, and fungi from cerebrospinal fluid (CSF), often crucial when conventional cultures are negative due to prior antibiotic use. Multiplex PCR panels allow detection of multiple pathogens simultaneously and real-time PCR (rtPCR) for rapid, quantitative detection
    Meningitis
  • Mast.jpgMast.jpg
    Syndromic PCR Assays
    Respiratory
    Syndromic panels for respiratory molecular assays allow for simultaneous detection of a broad range of pathogens, reducing the need for multiple, individual tests from a single patient sample. Highly sensitive molecular diagnostic methods provide superior accuracy in identifying pathogens compared to traditional culture or antigen tests and shorter turn around times aiding timely clinical decisions
    Respiratory
  • Mast.jpgMast.jpg
    Syndromic PCR Assays
    Miscellaneous
    Other highly sensitive molecular diagnostic assays to aid and inform clinical decision making.
    Miscellaneous
  • Mast.jpgMast.jpg
    Syndromic PCR Assays
    Sexually Transmitted Infections (STI)
    Use molecular syndromic STI panels to detect bacteria, viruses, and parasites from swab or urine samples.
    Sexually Transmitted Infections (STI)
  • Mast.jpgMast.jpg
    Syndromic PCR Assays
    Tuberculosis
    Rapid nucleic acid amplification tests (NAATs) to detect M.tuberculosis DNA and multi-line drug resistance. Rapid turn around times compared with traditional culture.
    Tuberculosis